Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 8 di 8
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
CA-IMT and QT parameters in dyslipidemic patients in primary prevention at different ESC/EAS cardiovascular risk levels 1-giu-2013 C. PavanelloM. TrioloP. MagniL. Calabresi + Conference Object -
Cardiovascular determinants of QT interval duration in dysplipidemic patients in primary prevention in two genders 1-giu-2013 C. PavanelloM. Triolo + Conference Object -
Impact of HBV therapy on the incidence of hepatocellular carcinoma 1-gen-2014 TRIOLO, MICHELAM. Colombo + Article (author) -
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis 1-gen-2018 Triolo M.La Mura V. + Article (author) -
Multimodality treatment of hepatocellular carcinoma : How field practice complies with international recommendations 23-mag-2018 Triolo, MichelaIavarone, MassimoRossi, GiorgioLa Mura, VincenzoColombo, MassimoLampertico, Pietro + Article (author) -
High rates of 30-day mortality in patients with cirrhosis and COVID-19 1-gen-2020 Triolo M.Massironi S.Aghemo A.Pedaci M.Rimondi A.Rumi M. G.Bonfanti P.Lampertico P. + Article (author) -
Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis 15-gen-2020 Triolo, MichelaLa Mura, Vincenzo + Article (author) -
Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort 1-apr-2020 La Mura V.Triolo M. + Article (author) -
Mostrati risultati da 1 a 8 di 8
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile